We are a team of experts dedicated to humanizing healthcare decisions and policies for life sciences companies. Through strategic stakeholder engagement and evidence-based insights, we help clients navigate complex environments, ensuring healthcare solutions are both impactful and patient-centered.
We are a team of experts dedicated to humanizing healthcare decisions and policies for life sciences companies. Through strategic stakeholder engagement and evidence-based insights, we help clients navigate complex environments, ensuring healthcare solutions are both impactful and patient-centered.
CREATIVE EXPERTS
Andras is an advocacy, market access and public affairs strategist who until 2023 served as Global Head Public & Government Affairs for Boehringer-Ingelheim. He previously was Senior Advisor to FTI Consulting’s healthcare practice, and senior functional leadership positions with Amgen, Novartis, and Eli Lilly & Co. Andras was a member of the EU Committee of Experts on Rare Diseases (EUCERD) and a founder of Rare Cancers Europe. He holds an MBA from INSEAD, a MALD from the Fletcher School of Law & Diplomacy, and a MA in Security Studies from the IHEID Graduate Institute in Geneva. He has authored publications in health, human rights and services and is a frequent moderator and speaker.
Valentine is an independent consultant whose current portfolio of activities include development of go-to-market strategies for companies in the area of psychedelics. Her previous experience includes Life Science and Healthcare Senior Consultant with both IQVIA and Monitor Deloitte. She is a graduate of Imperial College London with a Master of Engineering (Meng), Biomaterials and Tissue Engineering.
Oliver is a global market access & pricing executive with a finance background. He spent 20 years with Amgen in a variety of value, access and policy roles. His experience lies in life cycle management, launch access and label expansion strategies, portfolio and pipeline strategy. He is passionate about improving patient access and outcomes via smart access strategies and cross-functional collaboration. Oliver speaks 6 languages proficiently. His initial degree was in philosophy, followed by a MSC in economics and an MBA.
Patrick is a global market access expert with over 25 years experience at Bristol Myers Squibb and GlaxoSmithkline in executive HEOR, access, policy and commercial roles. An industry thought leader and regular conference speaker he is passionate about transforming the life science industry and health care stakeholder relationship by focusing on value and the sustainability of health care. He holds degrees in Pharmacy, Health Economics (MSc) and an MBA.
Michal Konstacky has over 20 years of global experience in Medical Affairs, Clinical Development, and Drug Launches at Roche, Takeda, AstraZeneca, and others. He has led global teams, driven regulatory approvals (FDA & EMA), and launched therapies across neurosciences, rare diseases, cardiometabolic, immunology, respiratory, and GI. A passionate advocate for translational medicine and AI-driven healthcare solutions, Michal ensures research translates into real-world patient impact.
Emil Tsenov is a marketing strategist and patient advocate with 30+ years of experience across healthcare, media, and consumer industries. As founder of the HCM Patient Foundation, he bridges strategic marketing, policy, and advocacy to drive patient-centric awareness and engagement. Emil has advised pharmaceutical companies on patient engagement strategies and teaches Marketing Strategy and Product Development at universities in Austria and the United States
Christine Bouchet is a healthcare strategist with 20+ years of experience in Market Access, HEOR, and Medical Affairs, including 18 years at Novartis. With an MD and advanced degrees in Clinical Epidemiology, Health Economics, and Computer Science, she specializes in evidence generation, reimbursement strategy, and medical policy shaping. Christine helps optimize product value and access, ensuring innovative therapies reach patients effectively.
Francesco Patalano is a pharmaceutical leader with 30+ years in Clinical Development, Medical Affairs, and Market Access. A pioneer in Patient-Reported Outcomes (PROs) and Patient-Focused Medicines Development (PFMD), he has successfully led drug approvals and public-private initiatives to integrate patient insights into development strategies. Francesco holds a Medical Degree and specialty certifications in Pulmonary Diseases and Immunology and has led R&D and manufacturing organizations in Europe and Canada.
We craft customized approaches to navigate your unique challenges and opportunities.
Our research transforms complex data into clear, impactful solutions.
We help shape policies that align with your vision and goal
Together, we build connections that drive sustainable and meaningful change.
OUR VALUES
We build trust through transparency, honesty, and a steadfast commitment to ethical practices.
We embrace creativity to develop bold, forward-thinking solutions that redefine healthcare possibilities.
We foster meaningful partnerships, uniting diverse perspectives to achieve impactful results.
We prioritize the well-being and voices of patients, ensuring their needs guide every decision we make.
Stay updated with the latest in healthcare innovation, policy insights, and patient-focused strategies. Subscribe to our newsletter and get exclusive updates delivered straight to your inbox.
Thank you for Subscribing!
You’re now part of our community. Stay tuned for updates, insights, and inspiring stories as we shape the future of patient-centered healthcare together.
We’re excited to have you on board!
Something Went Wrong!
It looks like there was an issue with your subscription. Please try again or contact us (info@creativepartners.health) if the problem persists. We’re here to help and can’t wait to welcome you to our community!
Creative Partners in Health GmbH
Hohlweg 2
4125 Riehen
phone 0000 / 000 000 00
info@creativepartners.health
www.creativepartners.health